Doo Young Jung
Founder & Chief Executive Officer Pinot Bio
Founder and CEO of Pinotbio, Inc. Invented a novel proprietary Top1i payload, PBX-7016, a hydrophilic, tandem-cleavage linker system and brought them through INDs. Experienced and versatile Ph. D., pharmaceutical R&D/scientific affairs professional. Various experiences in oncology R&D, including Top1i payload ADC.
Seminars
Wednesday 10th June 2026
Panel Discussion: Hearing Korean ADC Developers’ Perspectives on ADC Development to Accelerate Innovation & Establish South Korea as a Hub of ADC Development
9:00 am
- Honing insights from ADC pioneers in South Korea on cutting-edge research and lessons learned that are driving innovations
- Understanding how partnerships with pharma are accelerating ADC development
- Analyzing the future direction of ADC development to strengthen Korea’s global leadership in next-generation ADC therapeutics
Thursday 11th June 2026
Discovery & Preclinical Characterization of PBX-004, Potential Best-In-Class ITGB6 Targeting ADC
12:30 pm
- Introducing design of PBX-004, potential best-in-class ADC targeting ITGB6
- Highlighting efficacy and safety data of PBX-004 obtained in preclinical development
- Leveraging proprietary Top1i payload, PBX-7016 to achieve good efficacy/safety balance of ADC
